Synapse - Jose Baselga

Search Within

Jose T Baselga

Results (149)

Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence

Journal Article

Yang, C.; Li, Z.; Bhatt, T.; Dickler, M.; Giri, D.; Scaltriti, M.; Baselga, J.; Rosen, N.; Chandarlapaty, S.
Oncogene (2017)

Fulltext@MSK | Save

Analysis of CDH1 in invasive lobular carcinoma (ILC): Comparison of morphology, immunohistochemistry (IHC) and mutation profile detected by hybrid capture-based next generation sequencing (NGS)

Meeting Abstract

Grabenstetter, A.; Mohanty, A. S.; Zehir, A.; Razavi, P.; Baselga, J.; Tan, L. K.; Ross, D. S.
Modern Pathology (2017)

Fulltext@MSK | Save

Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy

Meeting Abstract

Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; more...
Cancer Research (2017)

Fulltext@MSK | Save

Analysis of CDH1 in invasive lobular carcinoma (ILC): Comparison of morphology, immunohistochemistry (IHC) and mutation profile detected by hybrid capture-based next generation sequencing (NGS)

Meeting Abstract

Grabenstetter, A.; Mohanty, A. S.; Zehir, A.; Razavi, P.; Baselga, J.; Tan, L. K.; Ross, D. S.
Laboratory Investigation (2017)

Fulltext@MSK | Save

Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR+, HER2-advanced breast cancer: Results from BOLERO-2

Journal Article

Moynahan, M. E.; Chen, D.; He, W.; Sung, P.; Samoila, A.; You, D.; Bhatt, T.; Patel, P.; Ringeisen, F.; Hortobagyi, G. N.; more...
British Journal of Cancer (2017)

Fulltext@MSK | Save

Pathologic complete response with neoadjuvant doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab and pertuzumab in patients with HER2-positive early stage breast cancer: A single center experience

Journal Article

Singh, J. C.; Mamtani, A.; Barrio, A.; Morrow, M.; Sugarman, S.; Jones, L. W.; Yu, A. F.; Argolo, D.; Smyth, L. M.; Modi, S.; more...
The Oncologist (2017)

Fulltext@MSK | Save

Activating ESR1 mutations differentially affect the efficacy of ER antagonists

Journal Article

Toy, W.; Weir, H.; Razavi, P.; Lawson, M.; Goeppert, A. U.; Mazzola, A. M.; Smith, A.; Wilson, J.; Morrow, C.; Wong, W. L.; more...
Cancer Discovery (2017)

Fulltext@MSK | Save

Next-generation assessment of human growth factor receptor 2 (ERBB2) amplification status: Clinical validation in the context of a hybrid capture-based, comprehensive solid tumor genomic profiling assay

Journal Article

Ross, D. S.; Zehir, A.; Cheng, D. T.; Benayed, R.; Nafa, K.; Hechtman, J. F.; Janjigian, Y. Y.; Weigelt, B.; Razavi, P.; Hyman, D. M.; more...
Journal of Molecular Diagnostics (2017)

Fulltext@MSK | Save

Prevalence of clonal hematopoiesis in patients with advanced cancer

Meeting Abstract

Zehir, A.; Coombs, C. C.; Devlin, S.; Kishtagari, A.; Hyman, D. M.; Solit, D. B.; Robson, M. E.; Baselga, J.; Arcila, M. E.; Tallman, M. S.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Pilot trial of an implantable microdevice for in vivo drug sensitivity testing in patients with early stage, triple negative breast cancer receiving neoadjuvant therapy

Meeting Abstract

Traina, T. A.; Plitas, G.; Reis-Filho, J. S.; Morris, E. A.; Hughes, M.; Sung, J. S.; Patil, S.; Piscuoglio, S.; Park, S.; Greenberg, C.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save